237064-55-0 Usage
General Description
2-((pyridin-2-yl)Methyl)hydrazine hydrochloride is an organic compound with the chemical formula C7H10N3.Cl. It is a hydrazine derivative that is commonly used as a building block in the synthesis of pharmaceutical compounds and agrochemicals. It has been found to exhibit antitumor and antiviral activities, making it a potential candidate for drug development. The hydrochloride salt form of the compound is water-soluble, making it easier to handle and use in various applications. Despite its promising pharmacological properties, further research is needed to fully understand its potential therapeutic uses and to ensure its safety for human consumption.
Check Digit Verification of cas no
The CAS Registry Mumber 237064-55-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,7,0,6 and 4 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 237064-55:
(8*2)+(7*3)+(6*7)+(5*0)+(4*6)+(3*4)+(2*5)+(1*5)=130
130 % 10 = 0
So 237064-55-0 is a valid CAS Registry Number.
237064-55-0Relevant articles and documents
Design, synthesis and antiviral activity of novel pyridazines
Wang, Ziwen,Wang, Mingxiao,Yao, Xue,Li, Yue,Tan, Juan,Wang, Lizhong,Qiao, Wentao,Geng, Yunqi,Liu, Yuxiu,Wang, Qingmin
experimental part, p. 33 - 41 (2012/09/08)
A series of pyridazines were prepared and evaluated for their anti-HIV activity. The new synthetic route involving a novel rearrangement reaction provided a practical method for the preparation of 5-hydroxypyridazines. The primary bioassay results indicated that most of the pyridazines possess anti-HIV activity. It ought to been mentioned that the rearranged compounds 35 and 39 exhibited relatively higher HIV inhibitory effect. Most of the synthesized compounds were also found to possess good anti-TMV activity, of which compound 9 showed similar in vivo anti-TMV activity to commercial plant virucide Ribavirin. This work provides a new and efficient approach to evolve novel multi-functional antiviral agents by rational integration and optimization of previously reported antiviral agents.
